[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363560-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363560-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mechanobiology-of-cancer-associated-thrombosis-from-molecular-mechanisms-to-therapeutic-innovation","Mechanobiology of cancer-associated thrombosis - from molecular mechanisms to therapeutic innovation","","Cancer-associated thrombosis (CAT) is the second leading cause of death in cancer patients, with venous thromboembolism affecting 20–30% of cases. Conventional biochemical models incompletely explain the spatial heterogeneity and therapeutic resistance of CAT. This review proposes a mechanobiology-centered framework integrating physical forces (aberrant hemodynamics, elevated interstitial pressure, matrix stiffening) with cellular mechanotransduction, linking mechanical cues to PIEZO1/integrin/YAP-TAZ signaling and downstream prothrombotic outputs. It also highlights RBC mechanobiology, microfluidic modeling, and upstream pathway targeting for precision thromboprophylaxis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mechanobiology-of-cancer-associated-thrombosis-from-molecular-mechanisms-to-therapeutic-innovation/363560/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mechanobiology-of-cancer-associated-thrombosis-from-molecular-mechanisms-to-therapeutic-innovation/363560.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the review address in current CAT models?","Question",{"text":63,"@type":64},"Conventional models focused on biochemical mediators such as tissue factor and inflammatory cytokines do not fully explain CAT’s spatial heterogeneity and therapeutic resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which mechanical cues and pathways are linked to thrombogenesis in the review?",{"text":68,"@type":64},"Aberrant hemodynamics, elevated interstitial pressure, and matrix stiffening activate mechanotransduction pathways including PIEZO1 channels, integrin–focal adhesion signaling, and YAP/TAZ transcriptional programs.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic strategies does the review suggest based on mechanobiology?",{"text":72,"@type":64},"Target upstream mechanosensitive pathways such as PIEZO1 modulation, YAP/TAZ-TEAD inhibition, and membrane tension control, aiming to reduce prothrombotic outputs while preserving hemostasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363560,1790505683,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Wang et al. Journal of Nanobiotechnology (2026) 24:524  \n[https://doi.org/10.1186/s12951-026-04411-4](https://doi.org/10.1186/s12951-026-04411-4)  \nJournal of Nanobiotechnology  \nREVIEW Open Access  \nMechanobiology of cancer-associated thrombosis: from molecular mechanisms to therapeutic innovation  \nZilinTonya Wang1,2, Yixuan Ria Hu1,2,3, Zilong Zhan2,3,4, Alexander Dupuy1,2,5, Zhian Yao1, Xuyu Liu2,3,4* and Lining Arnold Ju1,2,3,5*  \nAbstract  \nCancer-associated thrombosis (CAT) is the second leading cause of death in cancer patients, with venous thromboembolism affecting 20–30% of cases. While conventional models emphasize biochemical mediators such as tissue factor (TF) and inflammatory cytokines, they incompletely explain the spatial heterogeneity and therapeutic resistance of CAT. This review presents a mechanobiology-centered framework that integrates physical forces—including aberrant hemodynamics, elevated interstitial pressure, and matrix stiffening—with cellular mechanotransduction to explain thrombogenesis in malignancy. We examine how tumor-induced mechanical cues activate PIEZO1 channels, integrin-focal adhesion signaling, and YAP/TAZ transcriptional programs, collectively driving TF expression, extracellular vesicle release, platelet hyperreactivity, and neutrophil extracellular trap formation. Red blood cells (RBCs) emerge as underappreciated mechanobiological contributors through rheologydependent and phosphatidylserine-mediated mechanisms. Advanced microfluidic platforms recapitulating tumorspecific shear conditions enable mechanistic dissection and compound screening under physiologically relevant flow. Therapeutic strategies targeting upstream mechanosensitive pathways—including PIEZO1 modulation, YAP/TAZ-TEAD inhibition, and membrane tension control—offer potential to attenuate prothrombotic outputs while preserving hemostasis. Integration of mechanobiological biomarkers with machine-learning risk models may enhance CAT prediction beyond current clinical scores. This multi-scale perspective bridges molecular mechanosensors to tissue-level hemodynamics, establishing a foundation for precision thromboprophylaxis informed by the mechanical phenotype of individual tumors.  \nKeywords Thrombosis, Cancer, Mechanobiology, Extracellular vesicles, Tissue factor  \n*Correspondence:  \nXuyu Liu [xuyu.liu@sydney.edu.au](xuyu.liu@sydney.edu.au)[ ](xuyu.liu@sydney.edu.au)Lining Arnold Ju [arnold.ju@sydney.edu.au](arnold.ju@sydney.edu.au)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWang et al. Journal of Nanobiotechnology (2026) 24:524 Page 2 of 22  \nGraphical Abstract  \nCreated with [BioRender.com](BioRender.com).  \nIntroduction  \nCAT has emerged as a critical clinical challenge, representing the second leading cause of death in cancer patients after disease progressio","cbCaieThExw9MBNf","https://ap.wps.com/l/cbCaieThExw9MBNf","pdf",4425133,22,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the review address in current CAT models?\",\"answer\":\"Conventional models focused on biochemical mediators such as tissue factor and inflammatory cytokines do not fully explain CAT’s spatial heterogeneity and therapeutic resistance.\"},{\"question\":\"Which mechanical cues and pathways are linked to thrombogenesis in the review?\",\"answer\":\"Aberrant hemodynamics, elevated interstitial pressure, and matrix stiffening activate mechanotransduction pathways including PIEZO1 channels, integrin–focal adhesion signaling, and YAP/TAZ transcriptional programs.\"},{\"question\":\"What therapeutic strategies does the review suggest based on mechanobiology?\",\"answer\":\"Target upstream mechanosensitive pathways such as PIEZO1 modulation, YAP/TAZ-TEAD inhibition, and membrane tension control, aiming to reduce prothrombotic outputs while preserving hemostasis.\"}]","Mechanobiology of cancer-associated thrombosis - from molecular mechanisms to therapeutic innovation | PDF",1790151846,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07e4a58341d0bc4aa6baa0643c67b0e8.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b91d1b140be847ba55b2aa3c687e4d3.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af9090b0d8b14fecd2454ceb6e52107b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e13149081a7e1c7be318ff0c24c22f7.webp",980,1306]